查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1233130

2023-2030 年按类型（远端甲癣、浅表白色甲癣、近端甲癣）、治疗方法（口服、局部）、按地区划分的甲癣市场规模、份额和趋势分析报告

Onychomycosis Market Size, Share & Trends Analysis Report By Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis), By Treatment (Oral, Topical), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

甲癣市场增长和趋势

Grand View Research, Inc. 的最新报告显示，全球甲真菌病市场从 2022 年到 2030 年将以 4.56% 的复合年增长率增长，预计到 2030 年将达到 49.2 亿美元

甲癣市场的增长归因于甲癣和慢性病发病率的增加，以及治疗意识的提高。 传染病会造成心理和社会局限性，并会干扰工作和社交生活，因此为患有传染病的患者提供有效和高效的治疗非常重要。进一步促进增长。

甲癣发病率的上升是促进整个市场增长的主要因素。 这种感染称为趾甲真菌或真菌性指甲感染，影响美国总人口的 14% 以上。 然而，指甲真菌具有高度传染性，大多数人都没有意识到它的危害，儘管患上它的风险会随着年龄的增长而增加。

全球灰指甲组织等国际组织正在与世界各地的公共卫生当局和医疗保健专业人员合作，以提高全世界对灰指甲的认识，改善预防和治疗。是。 预计这将推动对治疗药物的需求。 美国疾病控制和预防中心 (CDC) 发起的“Think Fungus”等政府举措强调了早期发现和适当治疗真菌病（如患者的甲癣）的重要性。。 因此，预计对甲癣药物的需求将飙升，从而推动该国的市场增长。

此外，主要参与者正专注于联合研究和合作伙伴关係，以开发新型甲癣治疗方法并保持市场竞争力。 例如，2022 年 8 月，Moberg Pharma AB 将与 Padagis Israel Agencies Ltd. 签订分销协议，授予 Padagis 在以色列独家销售和营销 MOB-015（一种治疗甲癣的药物）的权利。 此外，解决诸如提高患者依从性和减少剂量等问题的创新有望推动市场增长。 例如，2021 年 10 月，Intus Pharmaceuticals 推出了商品名为 Itaspor-SB Forte/Subawin 的 SB 100mg，这是世界上第一个具有超强生物利用度的伊曲康唑。 这一举措有望显着提高患者的依从性并降低治疗成本。

甲癣市场报告要点

  • 远端甲下癣细分市场将在 2022 年占据市场主导地位，原因是 FDA 为满足不断增长的需求而批准的仿製药数量不断增加。
  • 由于外用药物易于使用和管理，可提高患者的依从性，因此预计在预测期内其增长率最快。
  • 竞争对手专注于获得资本密集型专业能力，以加强和保持竞争优势。
  • 北美在 2022 年占据了最大的市场份额，这可能是由于更容易获得医疗保健、更广泛的人口覆盖率和更高的治疗普及率。

内容

第 1 章甲癣市场：研究方法和范围

  • 市场细分
    • 细分范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的详细信息
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法按国家/地区进行市场预测
      • 方法 2：使用自上而下的方法逐个国家/地区进行市场估算
  • 全球市场：CAGR 计算
  • 次要信息列表
  • 目的
  • 缩写列表

第 2 章甲癣市场：执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章甲真菌病市场：行业展望

  • 市场系列展望
    • 母市场沿袭预测
    • 相关/子公司市场前景
  • 描绘渗透率和增长前景
  • 市场动态
    • 市场驱动力
      • 甲癣和慢性病的发病率增加
      • 提高对甲癣治疗的认识
      • 玩家加大研发力度
      • 老年人口和糖尿病人口增加
    • 市场製约因素分析
      • 增加抗真菌药物的耐药性
  • SWOT 分析，按因素（政治和法律、经济和技术）
  • 行业分析 - 搬运工
  • 报销和监管场景
  • 主要交易和战略联盟
    • 新产品发布
    • 得到
    • 分机
    • 伙伴关係
    • 营销和推广

第 4 章甲真菌病市场：竞争格局

  • 近期发展和影响分析：主要市场进入者
    • 安索夫矩阵
  • 公司分类
    • 创新者
      • 市场差异化因素
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
    • 2022 年主要参与者的市场份额分析
  • 上市公司
    • 竞争仪錶盘分析
  • 私人公司
    • 主要初创企业名单
  • 本地网络地图

第 5 章甲癣市场：类型业务分析

  • 定义和范围
  • 类型市场份额分析，2022 年和 2030 年
  • 全球甲癣市场，按类型，2018-2030 年
  • 甲癣市场：类型变异分析
  • 远端甲下甲癣
  • 白色浅癣甲癣
  • 近端甲下甲癣
  • 其他类型

第 6 章甲癣市场：治疗业务分析

  • 定义和范围
  • 2022 年和 2030 年治疗市场份额分析
  • 全球甲癣市场，按治疗方式，2018-2030 年
  • 结核病治疗市场：治疗波动分析
  • 口语
  • 主题
  • 其他

第 7 章。甲癣市场：区域业务分析

  • 定义和范围
  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场概况
  • SWOT 分析，按因素（政治和法律、经济和技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 多边环境协定
  • 2022-2030 年市场规模、预测、趋势分析
  • 北美
    • 美国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 加拿大
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
  • 欧洲
    • 英国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 德国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 西班牙
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 法国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 意大利
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 俄罗斯
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 丹麦
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 瑞典
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 挪威
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
  • 亚太地区
    • 日本
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 中国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 印度
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 韩国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 泰国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 澳大利亚
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
  • 拉丁美洲
    • 巴西
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 墨西哥
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 阿根廷
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
  • 多边环境协定
    • 南非
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 沙特阿拉伯
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景
    • 科威特
      • 主要国家动态
      • 监管框架
      • 竞争场景
      • 导入导出场景
      • 投资场景

第 8 章甲癣市场：公司概况

  • 公司简介
    • Bausch Health Companies Inc.,
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 葛兰素史克
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 雅培
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • F. 辉瑞公司，
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 拜耳公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 梯瓦製药工业有限公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 西普拉公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 诺华公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 太阳製药工业有限公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 默克公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-031-4

Onychomycosis Market Growth & Trends:

The global onychomycosis market is expected to reach USD 4.92 billion by 2030, expanding at a CAGR of 4.56% from 2022 to 2030, according to a new report by Grand View Research, Inc. The growth of the onychomycosis market is attributable to the increasing incidence of onychomycosis and chronic diseases aided by rising awareness about treatment. The infection leads to psychological and social limitations which can limit an individual's ability to work and socialize which makes it important to provide effective and efficient treatment for patients suffering from the infection further propelling the market growth.

Rising rate of onychomycosis is the key factor contributing to the overall growth of the market. The infection, often known as toenail fungus or fungal nail infection, affects over 14% of the total population in the U.S. However, most people are unaware of how harmful toenail fungus is, despite it is extremely contagious in nature and increasing the risk of developing with age.

International organizations such as the Global Nail Fungus Organization are working with public health officials and healthcare professionals worldwide to increase awareness and improve the prevention and treatment of nail fungus across the globe. This is anticipated to propel the demand for therapeutics. Government initiatives such as Think Fungus by the Centers for Disease Control and Prevention (CDC), emphasize the significance of detecting fungal diseases such as onychomycosis, early enough in the course of a patient's condition to ensure the administration of relevant therapy. This is inducing a surge in demand for onychomycosis therapeutics and is expected to drive market growth in the country.

Furthermore, the key players are focusing on collaborations and partnerships to develop novel onychomycosis therapies and to maintain their competitive position in the market. For instance, in August 2022, Moberg Pharma AB entered into a distribution agreement with Padagis Israel Agencies Ltd. that is expected to give Padagis exclusive rights for selling and marketing MOB-015, a treatment for onychomycosis in Israel. Moreover, innovations to address the concerns such as improving patient compliance and reducing the dosage are expected to fuel the market growth. For instance, in October 2021, Intas Pharmaceuticals launched SB 100mg under the brand name Itaspor-SB Forte/Subawin which is the world's first Super Bioavailable Itraconazole. This initiative is expected to significantly increase patient compliance and reduce the cost of therapy.

Onychomycosis Market Report Highlights:

  • Distal subungual onychomycosis segment dominated the market in 2022 and is attributable to the increasing prevalence and number of generic approvals by the FDA to meet the rising demands
  • Topical segment is expected to show the fastest growth rate over the forecast period owing to ease of usage and administration which leads to increased patient compliance with treatment
  • Players have an increased focus on acquiring specialized capacities that are highly capital-intensive to develop and maintain their competitive position
  • North America held the largest market share in 2022 which can be attributed to better access to healthcare, the presence of a wide target population, and high adoption of treatment

Table of Contents

Chapter 1 Onychomycosis Market: Methodology And Scope

  • 1.1 Market Segmentation
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
      • 1.6.1.3 Approach 2: Country Wise Market Estimation Using Top Down Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 List Of Secondary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1
    • 1.9.2 Objective 2
  • 1.10 List Of Abbreviations

Chapter 2 Onychomycosis Market: Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Onychomycosis Market: Industry Outlook

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Lineage Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Drivers
      • 3.3.1.1 Increasing Incidence Of Onychomycosis And Chronic Diseases
      • 3.3.1.2 Rising Awareness About Treatment Of Onychomycosis
      • 3.3.1.3 Escalating R&D Efforts By Players
      • 3.3.1.4 Growing Geriatric Population And Diabetic Population
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Increasing Resistance To Antifungal Drugs
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.5 Industry Analysis - Porter's
  • 3.6 Reimbursement & Regulatory Scenario
  • 3.7 Major Deals & Strategic Alliances
    • 3.7.1 New Product Launch
    • 3.7.2 Acquisition
    • 3.7.3 Expansion
    • 3.7.4 Partnerships
    • 3.7.5 Marketing & Promotions

Chapter 4 Onychomycosis Market: Competitive Landscape

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
    • 4.1.1 Ansoff Matrix
  • 4.2 Company Categorization
    • 4.2.1 Innovators
      • 4.2.1.1 Market Differentiators
  • 4.3 Vendor Landscape
    • 4.3.1 List Of Key Distributors And Channel Partners
    • 4.3.2 Key Customers
    • 4.3.3 Key Company Market Share Analysis, 2022
  • 4.4 Public Companies
    • 4.4.1 Competitive Dashboard Analysis
  • 4.5 Private Companies
    • 4.5.1 List Of Key Emerging Companies
  • 4.6 Regional Network Map

Chapter 5 Onychomycosis Market: Type Business Analysis

  • 5.1 Definition And Scope
  • 5.2 Type Market Share Analysis, 2022 & 2030
  • 5.3 Global Onychomycosis Market, By Type, 2018 To 2030
  • 5.4 Onychomycosis Market: Type Movement Analysis
  • 5.5 Distal Subungual Onychomycosis
    • 5.5.1 Distal Subungual Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 White Superficial Onychomycosis
    • 5.6.1 White Superficial Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Proximal Subungual Onychomycosis
    • 5.7.1 Proximal Subungual Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Other Types
    • 5.8.1 Other Types Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Onychomycosis Market: Treatment Business Analysis

  • 6.1 Definition And Scope
  • 6.2 Treatment Market Share Analysis, 2022 & 2030
  • 6.3 Global Onychomycosis Market, By Treatment, 2018 To 2030
  • 6.4 Tuberculosis Therapeutics Market: Treatment Movement Analysis
  • 6.5 Oral
    • 6.5.1 Oral Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Topical
    • 6.6.1 Topical Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Onychomycosis Market: Regional Business Analysis

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2022 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 MEA
  • 7.6 Market Size, & Forecasts, Trend Analysis, 2022 To 2030
  • 7.7 North America
    • 7.7.1 North America Onychomycosis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.7.2 U.S.
      • 7.7.2.1 U.S. Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.7.2.2 Key Country Dynamics
      • 7.7.2.3 Regulatory Framework
      • 7.7.2.4 Competitive Scenario
      • 7.7.2.5 Import Export Scenario
      • 7.7.2.6 Investments Scenario
    • 7.7.3 Canada
      • 7.7.3.1 Canada Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.7.3.2 Key Country Dynamics
      • 7.7.3.3 Regulatory Framework
      • 7.7.3.4 Competitive Scenario
      • 7.7.3.5 Import Export Scenario
      • 7.7.3.6 Investments Scenario
  • 7.8 Europe
    • 7.8.1 Europe Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.8.2 U.K.
      • 7.8.2.1 U.K. Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.2.2 Key Country Dynamics
      • 7.8.2.3 Regulatory Framework
      • 7.8.2.4 Competitive Scenario
      • 7.8.2.5 Import Export Scenario
      • 7.8.2.6 Investments Scenario
    • 7.8.3 Germany
      • 7.8.3.1 Germany Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.3.2 Key Country Dynamics
      • 7.8.3.3 Regulatory Framework
      • 7.8.3.4 Competitive Scenario
      • 7.8.3.5 Import Export Scenario
      • 7.8.3.6 Investments Scenario
    • 7.8.4 Spain
      • 7.8.4.1 Spain Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.4.2 Key Country Dynamics
      • 7.8.4.3 Regulatory Framework
      • 7.8.4.4 Competitive Scenario
      • 7.8.4.5 Import Export Scenario
      • 7.8.4.6 Investments Scenario
    • 7.8.5 France
      • 7.8.5.1 France Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.5.2 Key Country Dynamics
      • 7.8.5.3 Regulatory Framework
      • 7.8.5.4 Competitive Scenario
      • 7.8.5.5 Import Export Scenario
      • 7.8.5.6 Investments Scenario
    • 7.8.6 Italy
      • 7.8.6.1 Italy Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.6.2 Key Country Dynamics
      • 7.8.6.3 Regulatory Framework
      • 7.8.6.4 Competitive Scenario
      • 7.8.6.5 Import Export Scenario
      • 7.8.6.6 Investments Scenario
    • 7.8.7 Russia
      • 7.8.7.1 Russia Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.7.3 Regulatory Framework
      • 7.8.7.4 Competitive Scenario
      • 7.8.7.5 Import Export Scenario
      • 7.8.7.6 Investments Scenario
    • 7.8.8 Denmark
      • 7.8.8.1 Denmark Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.8.2 Key Country Dynamics
      • 7.8.8.3 Regulatory Framework
      • 7.8.8.4 Competitive Scenario
      • 7.8.8.5 Import Export Scenario
      • 7.8.8.6 Investments Scenario
    • 7.8.9 Sweden
      • 7.8.9.1 Sweden Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.9.2 Key Country Dynamics
      • 7.8.9.3 Regulatory Framework
      • 7.8.9.4 Competitive Scenario
      • 7.8.9.5 Import Export Scenario
      • 7.8.9.6 Investments Scenario
    • 7.8.10 Norway
      • 7.8.10.1 Norway Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.8.10.2 Key Country Dynamics
      • 7.8.10.3 Regulatory Framework
      • 7.8.10.4 Competitive Scenario
      • 7.8.10.5 Import Export Scenario
      • 7.8.10.6 Investments Scenario
  • 7.9 Asia Pacific
    • 7.9.1 Asia-Pacific Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.9.2 Japan
      • 7.9.2.1 Japan Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.2.2 Key Country Dynamics
      • 7.9.2.3 Regulatory Framework
      • 7.9.2.4 Competitive Scenario
      • 7.9.2.5 Import Export Scenario
      • 7.9.2.6 Investments Scenario
    • 7.9.3 China
      • 7.9.3.1 China Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.3.2 Key Country Dynamics
      • 7.9.3.3 Regulatory Framework
      • 7.9.3.4 Competitive Scenario
      • 7.9.3.5 Import Export Scenario
      • 7.9.3.6 Investments Scenario
    • 7.9.4 India
      • 7.9.4.1 India Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.4.2 Key Country Dynamics
      • 7.9.4.3 Regulatory Framework
      • 7.9.4.4 Competitive Scenario
      • 7.9.4.5 Import Export Scenario
      • 7.9.4.6 Investments Scenario
    • 7.9.5 South Korea
      • 7.9.5.1 South Korea Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.5.2 Key Country Dynamics
      • 7.9.5.3 Regulatory Framework
      • 7.9.5.4 Competitive Scenario
      • 7.9.5.5 Import Export Scenario
      • 7.9.5.6 Investments Scenario
    • 7.9.6 Thailand
      • 7.9.6.1 Thailand Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.6.2 Key Country Dynamics
      • 7.9.6.3 Regulatory Framework
      • 7.9.6.4 Competitive Scenario
      • 7.9.6.5 Import Export Scenario
      • 7.9.6.6 Investments Scenario
    • 7.9.7 Australia
      • 7.9.7.1 Australia Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.9.7.2 Key Country Dynamics
      • 7.9.7.3 Regulatory Framework
      • 7.9.7.4 Competitive Scenario
      • 7.9.7.5 Import Export Scenario
      • 7.9.7.6 Investments Scenario
  • 7.10 Latin America
    • 7.10.1 Latin America Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.10.2 Brazil
      • 7.10.2.1 Brazil Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.10.2.2 Key Country Dynamics
      • 7.10.2.3 Regulatory Framework
      • 7.10.2.4 Competitive Scenario
      • 7.10.2.5 Import Export Scenario
      • 7.10.2.6 Investments Scenario
    • 7.10.3 Mexico
      • 7.10.3.1 Mexico Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.10.3.2 Key Country Dynamics
      • 7.10.3.3 Regulatory Framework
      • 7.10.3.4 Competitive Scenario
      • 7.10.3.5 Import Export Scenario
      • 7.10.3.6 Investments Scenario
    • 7.10.4 Argentina
      • 7.10.4.1 Argentina Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.10.4.2 Key Country Dynamics
      • 7.10.4.3 Regulatory Framework
      • 7.10.4.4 Competitive Scenario
      • 7.10.4.5 Import Export Scenario
      • 7.10.4.6 Investments Scenario
  • 7.11 MEA
    • 7.11.1 MEA Onychomycosis Market, 2018 - 2030 (USD Million)
    • 7.11.2 South Africa
      • 7.11.2.1 South Africa Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.2.2 Key Country Dynamics
      • 7.11.2.3 Regulatory Framework
      • 7.11.2.4 Competitive Scenario
      • 7.11.2.5 Import Export Scenario
      • 7.11.2.6 Investments Scenario
    • 7.11.3 Saudi Arabia
      • 7.11.3.1 Saudi Arabia Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.3.2 Key Country Dynamics
      • 7.11.3.3 Regulatory Framework
      • 7.11.3.4 Competitive Scenario
      • 7.11.3.5 Import Export Scenario
      • 7.11.3.6 Investments Scenario
    • 7.11.4 UAE
      • 7.11.4.1 UAE Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.4.2 Key Country Dynamics
      • 7.11.4.3 Regulatory Framework
      • 7.11.4.4 Competitive Scenario
      • 7.11.4.5 Import Export Scenario
      • 7.11.4.6 Investments Scenario
    • 7.11.5 Kuwait
      • 7.11.5.1 Kuwait Onychomycosis Market, 2018 - 2030 (USD Million)
      • 7.11.5.2 Key Country Dynamics
      • 7.11.5.3 Regulatory Framework
      • 7.11.5.4 Competitive Scenario
      • 7.11.5.5 Import Export Scenario
      • 7.11.5.6 Investments Scenario

Chapter 8 Onychomycosis Market: Company Profiling

  • 8.1 Company Profiles
    • 8.1.1 Bausch Health Companies Inc.,
      • 8.1.1.1 Company Overview
      • 8.1.1.2 Financial Performance
      • 8.1.1.3 Product Benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 Gsk Plc
      • 8.1.2.1 Company Overview
    • 8.1.2 2.Financial Performance
      • 8.1.2.3 Product Benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Abbott
      • 8.1.3.1 Company Overview
      • 8.1.3.2 Financial Performance
      • 8.1.3.3 Product Benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 F. Pfizer Inc.,
      • 8.1.4.1 Company Overview
      • 8.1.4.2 Financial Performance
      • 8.1.4.3 Product Benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 Bayer Ag
      • 8.1.5.1 Company Overview
      • 8.1.5.2 Financial Performance
      • 8.1.5.3 Product Benchmarking
      • 8.1.5.4 Strategic Initiatives
    • 8.1.6 Teva Pharmaceutical Industries, Ltd.
      • 8.1.6.1 Company Overview
      • 8.1.6.2 Financial Performance
      • 8.1.6.3 Product Benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 Cipla Inc.
      • 8.1.7.1 Company Overview
      • 8.1.7.2 Financial Performance
      • 8.1.7.3 Product Benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Novartis Ag
      • 8.1.8.1 Company Overview
      • 8.1.8.2 Financial Performance
      • 8.1.8.3 Product Benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 Sun Pharmaceutical Industries Ltd.
      • 8.1.9.1 Company Overview
      • 8.1.9.2 Financial Performance
      • 8.1.9.3 Product Benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 Merck & Co., Inc.
      • 8.1.10.1 Company Overview
      • 8.1.10.2 Financial Performance
      • 8.1.10.3 Product Benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 Incidence of Diseases
  • Table 4 Global Onychomycosis Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 North America Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 6 North America Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 7 North America Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 8 U.S. Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 10 Canada Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 Canada Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 12 Europe Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 13 Europe Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 14 Europe Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 15 Germany Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 16 Germany Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 17 U.K. Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 18 U.K. Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 19 France Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 20 France Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 21 Italy Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 22 Italy Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 23 Spain Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Spain Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 25 Denmark Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 27 Sweden Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 30 Norway Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Onychomycosis Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 34 Japan Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 35 Japan Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 36 China Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 37 China Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 38 India Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 39 India Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 40 South Korea Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 41 South Korea Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 42 Australia Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 43 Australia Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 44 Thailand Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 45 Thailand Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 46 Latin America Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 47 Latin America Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Latin America Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 49 Brazil Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 50 Brazil Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 51 Mexico Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Mexico Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 53 Argentina Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Onychomycosis Market, By Country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 60 South Africa Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 62 UAE Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 63 UAE Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Onychomycosis Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait Onychomycosis Market, By Treatment, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Onychomycosis Market Segmentation
  • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 11 Penetration & Growth Prospect Mapping
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping
  • Fig. 15 Onychomycosis market: Type outlook and key takeaways
  • Fig. 16 Onychomycosis market: Type movement analysis & market share 2022 & 2030
  • Fig. 17 Distal subungual onychomycosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 White superficial onychomycosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Proximal subungual onychomycosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Onychomycosis market: Treatment outlook and key takeaways
  • Fig. 22 Onychomycosis market: Treatment movement analysis & market share 2022 & 2030
  • Fig. 23 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Regional Marketplace: Key Takeaways
  • Fig. 27 Regional Outlook, 2022 & 2030
  • Fig. 28 Regional Market Dashboard
  • Fig. 29 Regional Market Place: Key Takeaways
  • Fig. 30 North America, SWOT Analysis
  • Fig. 31 Europe, SWOT Analysis
  • Fig. 32 Asia Pacific, SWOT Analysis
  • Fig. 33 Latin America, SWOT Analysis
  • Fig. 34 MEA, SWOT Analysis
  • Fig. 35 North America
  • Fig. 36 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 37 U.S.
  • Fig. 38 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Canada
  • Fig. 40 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Europe
  • Fig. 42 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 43 U.K.
  • Fig. 44 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Germany
  • Fig. 46 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 47 France
  • Fig. 48 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Italy
  • Fig. 50 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Spain
  • Fig. 52 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark
  • Fig. 54 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden
  • Fig. 56 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Norway
  • Fig. 58 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific
  • Fig. 60 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Japan
  • Fig. 62 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 63 China
  • Fig. 64 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 65 India
  • Fig. 66 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Australia
  • Fig. 68 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Thailand
  • Fig. 70 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea
  • Fig. 72 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America
  • Fig. 74 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Brazil
  • Fig. 76 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Mexico
  • Fig. 78 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Argentina
  • Fig. 80 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 81 MEA
  • Fig. 82 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa
  • Fig. 84 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia
  • Fig. 86 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 87 UAE
  • Fig. 88 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait
  • Fig. 90 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Strategy Mapping